Pharma Projected to Have ACA to Thank for Growth - Assuming it Remains As-Is
This article was originally published in RPM Report
Executive Summary
The Centers for Medicare and Medicaid’s Office of the Actuary projects that aggregate health care spending will grow modestly - then spike in 2014. That’s due to coverage expansions in the Affordable Care Act, and pharma stands to get among the biggest gains. The June report release means industry would have at least a couple weeks to enjoy the projections before they potentially no longer apply.
You may also be interested in...
Drug Shortage Could Be Addressed By ‘Resilience Rating’ From Private Entity Under HHS Plan
US HHS is proposing a public-private partnership to assign ratings to manufacturers based on quality/resilience of supply, tied to a purchasing incentive program for providers. The non-agency approach may be key to overcoming industry and political objections.
Drug Shortage Could Be Addressed By ‘Resilience Rating’ From Private Entity Under HHS Plan
US HHS is proposing a public-private partnership to assign ratings to manufacturers based on quality/resilience of supply, tied to a purchasing incentive program for providers. The non-agency approach may be key to overcoming industry and political objections.
A Final Push For US Hepatitis C Eradication Plan In 2024
The Biden Administration is hoping that it can attach funding for a national hepatitis C ‘subscription’ program into the delayed fiscal 2024 appropriations bills.